Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients

Opis bibliograficzny
Główni autorzy:	Sergijenko, A, Moiseenko, A, Pineault, K, Nafchi, NAM, Chan, M, Gamlen, T, Gill, D, Hyde, S, Kreuz, S, Griesenbach, U, Alton, EWFW
Format:	Conference item
Język:	English
Wydane:	Wiley 2020

Podobne zapisy

Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
od: Sergijenko, A, i wsp.
Wydane: (2021)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS IN A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
od: Griesenbach, U, i wsp.
Wydane: (2012)

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.
od: Griesenbach, U, i wsp.
Wydane: (2012)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS AS A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
od: Griesenbach, U, i wsp.
Wydane: (2012)

Towards a first-in-human trial with a pseudotyped lentivirus
od: Alton, EW, i wsp.
Wydane: (2020)

Single cell assays for quantifying MRNA and protein during cystic fibrosis gene therapy trials
od: Sinadinos, A, i wsp.
Wydane: (2020)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
od: Hyde, S, i wsp.
Wydane: (2015)

Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment
od: Sinadinos, A, i wsp.
Wydane: (2021)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
od: Davies, G, i wsp.
Wydane: (2011)

Development of protocols for mouse GLP-toxicology studies
od: Sinadinos, A, i wsp.
Wydane: (2020)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
od: Munday, RJ, i wsp.
Wydane: (2020)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
od: Munday, RJ, i wsp.
Wydane: (2022)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
od: Munday, RJ, i wsp.
Wydane: (2022)

Preparation for a first-in-man lentivirus trial in cystic fibrosis patients
od: Griesenbach, U, i wsp.
Wydane: (2016)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
od: Rosie J. Munday, i wsp.
Wydane: (2022-09-01)

Improving the quantification of rSIV.F/HN vectors for cystic fibrosis gene therapy using droplet digital PCR
od: Gamlen, T, i wsp.
Wydane: (2020)

A Functional <it>Henipavirus </it>Envelope Glycoprotein Pseudotyped Lentivirus Assay System
od: Broder Christopher C, i wsp.
Wydane: (2010-11-01)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF
od: Davies, J, i wsp.
Wydane: (2011)

Rapid determination of rSIV.F/HN lentiviral vector titre
od: Conway, CC, i wsp.
Wydane: (2020)

Assessment of CFTR function after gene transfer in vitro and in vivo.
od: Griesenbach, U, i wsp.
Wydane: (2008)

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.
od: Alton, E, i wsp.
Wydane: (2016)

Lentivirus gene therapy for autoimmune pulmonary alveolar proteinosis
od: Palau, H, i wsp.
Wydane: (2019)

Sendai virus-mediated CFTR gene transfer to the airway epithelium.
od: Ferrari, S, i wsp.
Wydane: (2007)

Large-scale, high-throughput production of rSIV.F/HN vectors
od: Viegas, MFA, i wsp.
Wydane: (2020)

Lentivirus GM-CSF gene therapy for autoimmune pulmonary alveolar proteinosis
od: Lund-Palau, H, i wsp.
Wydane: (2018)

597: Protocol development for mouse toxicology studies using lentiviral gene therapy
od: Sinadinos, A, i wsp.
Wydane: (2021)

CFTR dysfunction leads to defective bacterial eradication on cystic fibrosis airways
od: Min Wu, i wsp.
Wydane: (2024-04-01)

CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis
od: Francesca Saluzzo, i wsp.
Wydane: (2022-04-01)

Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy
od: Buqing Yi, i wsp.
Wydane: (2021-03-01)

Non-viral CFTR gene delivery to the lungs of Cystic Fibrosis patients
od: Hyde, S
Wydane: (2013)

Eucalyptus Essential Oil Inhibits Cell Infection by SARS-CoV-2 Spike Pseudotyped Lentivirus
od: Sara Alonso Fernandez, i wsp.
Wydane: (2024-08-01)

Transgenesis and Genome Editing of Mouse Spermatogonial Stem Cells by Lentivirus Pseudotyped with Sendai Virus F Protein
od: Takashi Shinohara, i wsp.
Wydane: (2020-03-01)

Self-reactive CFTR T cells in humans: implications for gene therapy.
od: Calcedo, R, i wsp.
Wydane: (2013)

Lentivirus GM-CSF gene therapy ameliorates autoimmune pulmonary alveolar proteinosis
od: Lund-Palau, H, i wsp.
Wydane: (2018)

Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticles
od: Ian Helstrup Nielsen, i wsp.
Wydane: (2024-12-01)

CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways
od: Sheylan D. Patel, i wsp.
Wydane: (2020-06-01)

Design and Development of a Pseudotyped-lentivirus for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
od: Hadi Hassannia, i wsp.
Wydane: (2023-11-01)

Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice.
od: Davies, L, i wsp.
Wydane: (2008)

Gene therapy for respiratory diseases; progress and a changing context
od: Alton, EWFW, i wsp.
Wydane: (2020)

Expression of gain-of-function CFTR in cystic fibrosis airway cells restores epithelial function better than wild-type or codon-optimized CFTR
od: Maximillian Woodall, i wsp.
Wydane: (2023-09-01)